853 related articles for article (PubMed ID: 11436121)
1. Analysis of the methylation status of the KCNQ1OT and H19 genes in leukocyte DNA for the diagnosis and prognosis of Beckwith-Wiedemann syndrome.
Gaston V; Le Bouc Y; Soupre V; Burglen L; Donadieu J; Oro H; Audry G; Vazquez MP; Gicquel C
Eur J Hum Genet; 2001 Jun; 9(6):409-18. PubMed ID: 11436121
[TBL] [Abstract][Full Text] [Related]
2. Epigenotype-phenotype correlations in Beckwith-Wiedemann syndrome.
Engel JR; Smallwood A; Harper A; Higgins MJ; Oshimura M; Reik W; Schofield PN; Maher ER
J Med Genet; 2000 Dec; 37(12):921-6. PubMed ID: 11106355
[TBL] [Abstract][Full Text] [Related]
3. Relaxation of insulin-like growth factor 2 imprinting and discordant methylation at KvDMR1 in two first cousins affected by Beckwith-Wiedemann and Klippel-Trenaunay-Weber syndromes.
Sperandeo MP; Ungaro P; Vernucci M; Pedone PV; Cerrato F; Perone L; Casola S; Cubellis MV; Bruni CB; Andria G; Sebastio G; Riccio A
Am J Hum Genet; 2000 Mar; 66(3):841-7. PubMed ID: 10712200
[TBL] [Abstract][Full Text] [Related]
4. Molecular subtypes and phenotypic expression of Beckwith-Wiedemann syndrome.
Cooper WN; Luharia A; Evans GA; Raza H; Haire AC; Grundy R; Bowdin SC; Riccio A; Sebastio G; Bliek J; Schofield PN; Reik W; Macdonald F; Maher ER
Eur J Hum Genet; 2005 Sep; 13(9):1025-32. PubMed ID: 15999116
[TBL] [Abstract][Full Text] [Related]
5. Increased tumour risk for BWS patients correlates with aberrant H19 and not KCNQ1OT1 methylation: occurrence of KCNQ1OT1 hypomethylation in familial cases of BWS.
Bliek J; Maas SM; Ruijter JM; Hennekam RC; Alders M; Westerveld A; Mannens MM
Hum Mol Genet; 2001 Mar; 10(5):467-76. PubMed ID: 11181570
[TBL] [Abstract][Full Text] [Related]
6. Tumor development in the Beckwith-Wiedemann syndrome is associated with a variety of constitutional molecular 11p15 alterations including imprinting defects of KCNQ1OT1.
Weksberg R; Nishikawa J; Caluseriu O; Fei YL; Shuman C; Wei C; Steele L; Cameron J; Smith A; Ambus I; Li M; Ray PN; Sadowski P; Squire J
Hum Mol Genet; 2001 Dec; 10(26):2989-3000. PubMed ID: 11751681
[TBL] [Abstract][Full Text] [Related]
7. Alterations of H19 imprinting and IGF2 replication timing are infrequent in Beckwith-Wiedemann syndrome.
Squire JA; Li M; Perlikowski S; Fei YL; Bayani J; Zhang ZM; Weksberg R
Genomics; 2000 May; 65(3):234-42. PubMed ID: 10857747
[TBL] [Abstract][Full Text] [Related]
8. Rapid detection of methylation change at H19 in human imprinting disorders using methylation-sensitive high-resolution melting.
Wojdacz TK; Dobrovic A; Algar EM
Hum Mutat; 2008 Oct; 29(10):1255-60. PubMed ID: 18473334
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic modification and uniparental inheritance of H19 in Beckwith-Wiedemann syndrome.
Catchpoole D; Lam WW; Valler D; Temple IK; Joyce JA; Reik W; Schofield PN; Maher ER
J Med Genet; 1997 May; 34(5):353-9. PubMed ID: 9152830
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of methylation status at 11p15 and 7q21 for the genetic diagnosis of Beckwith-Wiedemann syndrome and Silver-Russell syndrome.
Lee BH; Kim GH; Oh TJ; Kim JH; Lee JJ; Choi SH; Lee JY; Kim JM; Choi IH; Kim YM; Choi JH; Yoo HW
J Hum Genet; 2013 Sep; 58(9):604-10. PubMed ID: 23803580
[TBL] [Abstract][Full Text] [Related]
11. Molecular biology of Beckwith-Wiedemann syndrome.
Weksberg R; Squire JA
Med Pediatr Oncol; 1996 Nov; 27(5):462-9. PubMed ID: 8827075
[TBL] [Abstract][Full Text] [Related]
12. A maternally methylated CpG island in KvLQT1 is associated with an antisense paternal transcript and loss of imprinting in Beckwith-Wiedemann syndrome.
Smilinich NJ; Day CD; Fitzpatrick GV; Caldwell GM; Lossie AC; Cooper PR; Smallwood AC; Joyce JA; Schofield PN; Reik W; Nicholls RD; Weksberg R; Driscoll DJ; Maher ER; Shows TB; Higgins MJ
Proc Natl Acad Sci U S A; 1999 Jul; 96(14):8064-9. PubMed ID: 10393948
[TBL] [Abstract][Full Text] [Related]
13. Loss of imprinting of a paternally expressed transcript, with antisense orientation to KVLQT1, occurs frequently in Beckwith-Wiedemann syndrome and is independent of insulin-like growth factor II imprinting.
Lee MP; DeBaun MR; Mitsuya K; Galonek HL; Brandenburg S; Oshimura M; Feinberg AP
Proc Natl Acad Sci U S A; 1999 Apr; 96(9):5203-8. PubMed ID: 10220444
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the IGF2/H19 imprinting control region uncovers new genetic defects, including mutations of OCT-binding sequences, in patients with 11p15 fetal growth disorders.
Demars J; Shmela ME; Rossignol S; Okabe J; Netchine I; Azzi S; Cabrol S; Le Caignec C; David A; Le Bouc Y; El-Osta A; Gicquel C
Hum Mol Genet; 2010 Mar; 19(5):803-14. PubMed ID: 20007505
[TBL] [Abstract][Full Text] [Related]
15. Imprinting status of 11p15 genes in Beckwith-Wiedemann syndrome patients with CDKN1C mutations.
Li M; Squire J; Shuman C; Fei YL; Atkin J; Pauli R; Smith A; Nishikawa J; Chitayat D; Weksberg R
Genomics; 2001 Jun; 74(3):370-6. PubMed ID: 11414765
[TBL] [Abstract][Full Text] [Related]
16. Low frequency of p57KIP2 mutation in Beckwith-Wiedemann syndrome.
Lee MP; DeBaun M; Randhawa G; Reichard BA; Elledge SJ; Feinberg AP
Am J Hum Genet; 1997 Aug; 61(2):304-9. PubMed ID: 9311734
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic and genetic alterations of the imprinting disorder Beckwith-Wiedemann syndrome and related disorders.
Soejima H; Higashimoto K
J Hum Genet; 2013 Jul; 58(7):402-9. PubMed ID: 23719190
[TBL] [Abstract][Full Text] [Related]
18. [Beckwith-Wiedemann syndrome].
Yoshiura K; Niikawa N
Nihon Rinsho; 2000 Jul; 58(7):1511-4. PubMed ID: 10921333
[TBL] [Abstract][Full Text] [Related]
19. Regional loss of imprinting and growth deficiency in mice with a targeted deletion of KvDMR1.
Fitzpatrick GV; Soloway PD; Higgins MJ
Nat Genet; 2002 Nov; 32(3):426-31. PubMed ID: 12410230
[TBL] [Abstract][Full Text] [Related]
20. Microdeletions in the human H19 DMR result in loss of IGF2 imprinting and Beckwith-Wiedemann syndrome.
Sparago A; Cerrato F; Vernucci M; Ferrero GB; Silengo MC; Riccio A
Nat Genet; 2004 Sep; 36(9):958-60. PubMed ID: 15314640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
